CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial
- DOI
- 10.1016/j.eclinm.2024.102882
- Published
- 2024-11
- Container
- eClinicalMedicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2024.102882,
title = {CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial},
author = {Nicola L. Brice and Mark Carlton and David H. Margolin and Martin Bexon and Kim L. Matthews and Lee A. Dawson and Aaron L. Ellenbogen and C. Warren Olanow and Jordan Dubow and Karl Kieburtz},
year = {2024},
journal = {eClinicalMedicine},
doi = {10.1016/j.eclinm.2024.102882},
url = {https://doi.org/10.1016/j.eclinm.2024.102882}
}RIS
TY - JOUR TI - CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial AU - Nicola L. Brice AU - Mark Carlton AU - David H. Margolin AU - Martin Bexon AU - Kim L. Matthews AU - Lee A. Dawson AU - Aaron L. Ellenbogen AU - C. Warren Olanow AU - Jordan Dubow AU - Karl Kieburtz PY - 2024 JO - eClinicalMedicine DO - 10.1016/j.eclinm.2024.102882 UR - https://doi.org/10.1016/j.eclinm.2024.102882 ER -
APA
Brice, N. L., Carlton, M., Margolin, D. H., Bexon, M., Matthews, K. L., Dawson, L. A., Ellenbogen, A. L., Olanow, C. W., Dubow, J., & Kieburtz, K. (2024). CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2024.102882
Source records
- crossref · retrieved 2026-09-26T00:51:03.133Z